Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12032877rdf:typepubmed:Citationlld:pubmed
pubmed-article:12032877lifeskim:mentionsumls-concept:C0086409lld:lifeskim
pubmed-article:12032877lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:12032877lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:12032877lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:12032877lifeskim:mentionsumls-concept:C0132326lld:lifeskim
pubmed-article:12032877lifeskim:mentionsumls-concept:C0674428lld:lifeskim
pubmed-article:12032877lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:12032877lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:12032877pubmed:issue3lld:pubmed
pubmed-article:12032877pubmed:dateCreated2002-5-28lld:pubmed
pubmed-article:12032877pubmed:abstractTextA randomized, open-label, pilot study was undertaken to explore the antiviral activity and tolerability of two nonnucleoside reverse transcriptase inhibitors (NNRTIs), nevirapine (NVP) and efavirenz (EFV).lld:pubmed
pubmed-article:12032877pubmed:languageenglld:pubmed
pubmed-article:12032877pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032877pubmed:citationSubsetIMlld:pubmed
pubmed-article:12032877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12032877pubmed:statusMEDLINElld:pubmed
pubmed-article:12032877pubmed:issn1528-4336lld:pubmed
pubmed-article:12032877pubmed:authorpubmed-author:BarreiroPablo...lld:pubmed
pubmed-article:12032877pubmed:authorpubmed-author:SorianoVincen...lld:pubmed
pubmed-article:12032877pubmed:authorpubmed-author:González-Laho...lld:pubmed
pubmed-article:12032877pubmed:authorpubmed-author:NúñezMarinaMlld:pubmed
pubmed-article:12032877pubmed:authorpubmed-author:García-Benaya...lld:pubmed
pubmed-article:12032877pubmed:authorpubmed-author:BlancoFrancis...lld:pubmed
pubmed-article:12032877pubmed:authorpubmed-author:BarriosAnaAlld:pubmed
pubmed-article:12032877pubmed:authorpubmed-author:Martín-Carbon...lld:pubmed
pubmed-article:12032877pubmed:issnTypePrintlld:pubmed
pubmed-article:12032877pubmed:volume3lld:pubmed
pubmed-article:12032877pubmed:ownerNLMlld:pubmed
pubmed-article:12032877pubmed:authorsCompleteYlld:pubmed
pubmed-article:12032877pubmed:pagination186-94lld:pubmed
pubmed-article:12032877pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:meshHeadingpubmed-meshheading:12032877...lld:pubmed
pubmed-article:12032877pubmed:articleTitleSENC (Spanish efavirenz vs. nevirapine comparison) trial: a randomized, open-label study in HIV-infected naive individuals.lld:pubmed
pubmed-article:12032877pubmed:affiliationService of Infectious Diseases, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.lld:pubmed
pubmed-article:12032877pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12032877pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12032877pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12032877pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:12032877pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032877lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032877lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12032877lld:pubmed